Cagle Gerald D. 4
4 · Clearside Biomedical, Inc. · Filed Jun 26, 2018
Insider Transaction Report
Form 4
Cagle Gerald D.
Director
Transactions
- Exercise/Conversion
Common Stock
2018-06-25$8.81/sh+8,618$75,925→ 77,513 total - Exercise/Conversion
Common Stock
2018-06-25$9.11/sh+2,632$23,978→ 80,145 total - Exercise/Conversion
Stock Option (right to buy)
2018-06-25−8,618→ 0 totalExercise: $8.81From: 2018-06-20Exp: 2027-06-21→ Common Stock (8,618 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-06-25−2,632→ 0 totalExercise: $9.11From: 2018-06-20Exp: 2027-06-29→ Common Stock (2,632 underlying)
Holdings
- 14,064(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Cagle Business Interests, Ltd. is the record holder of these securities. The reporting person is the general partner of Cagle Business Interests, Ltd. and may be deemed to share voting and dispositive power over these securities. The reporting person disclaims beneficial ownership of these securities and this report is not an admission that the reporting person is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.